- £593.03m
- £601.58m
- £306.39m
Annual income statement for Cohort, fiscal year end - April 30th, GBP millions except per share, conversion factor applied.
2022 April 30th | 2023 April 30th | 2024 April 30th | 2025 April 30th | 2026 April 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 138 | 183 | 203 | 270 | 306 |
| Cost of Revenue | |||||
| Gross Profit | 57.6 | 63.9 | 73.4 | 87.2 | 101 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 125 | 167 | 181 | 244 | 272 |
| Operating Profit | 13.1 | 15.3 | 21.2 | 26.1 | 34.6 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 12.2 | 13.9 | 19.8 | 25.6 | 32.6 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 10.7 | 11.3 | 15.3 | 19.6 | 24.3 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 11.2 | 11.4 | 15.3 | 19.2 | 23.9 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 11.2 | 11.4 | 15.3 | 19.2 | 23.9 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.288 | 0.279 | 0.377 | 0.443 | 0.504 |
| Dividends per Share |